Oxford optimistic £115m diabetes centre will revive drug discovery and research

Oxford optimistic £115m diabetes centre will revive drug discovery and research

Oxford university is to host a £115m diabetes research centre funded over 10 years by Danish pharmaceutical company Novo Nordisk. Sir John Bell, Oxford’s professor of medicine and the government’s “life sciences champion”, said the investment signalled the revival of drug discovery research in the UK after a decade-long decline. “We once had 11 companies…

This content is for Standard & Premium Digital Subscribers only.
Log In Subscribe

Related Posts